Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

Benzinga · 2d ago
Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $35 to $40.